glp 1 agonist indications Benefits and Risks of GLP-1 Receptor Agonists Outlined Holding GLP-1 Agonists Prior to
Description
J.AkerstromV
The first GLP-1 medication, exenatide, was approved in 2005 under the brand name Byetta
Neuropsychopharmacology 42 , 14711479, (2017)
Semaglutide has no phenethylamine component
These outcomes were assessed using validated questionnaires, including the Binge Eating Scale (BES), Three-Factor Eating Questionnaire (TFEQ), and Statistical techniques were applied to calculate standardized mean differences, enabling comparison across studies with different scales
Evaluation of novel particles as an inhalation system for GLP-1
